Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Nuvo Pharmaceuticals Inc MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

OTCQX:MRVFF - Post Discussion

Nuvo Pharmaceuticals Inc > Market Cap - Too Low
View:
Post by NoCentsay on Aug 15, 2019 10:59am

Market Cap - Too Low

8 Million is way way too low for a comapny that just made 9 million this quarter, considering all factors. I would like to see a zero added on to that.
Comment by runmyownlife on Aug 16, 2019 1:59pm
.... And $14MM in cash and near cash.
Comment by lscfa on Aug 16, 2019 2:09pm
But enterprise value is $109  Million.... Long term debt $123 mil less working cap - $21 mil mkt cap $7.4 mil ($0.65 x 11.4 mil) = $109 mil
Comment by NoCentsay on Aug 16, 2019 4:04pm
 “If ifs and buts were candy and nuts, we’d all have a merry Christmas.” 
Comment by daydream1 on Aug 19, 2019 9:56am
Also, you have to be mindful that the presently traded share price is not just a reflection of the present financial book value only. It is the future value of the company that is reflected. If you look at all the patents from the Aralez acquisition you will notice that are only valid for 4 up to about 7 years, not mentioning  the recent loss of Vimovo rights. My opinion is the only investor ...more  
Comment by ValueCap on Aug 19, 2019 7:23pm
How is Deerfield going to benefit when their options are at 3.53/ share? They would get crushed if they executed now and further dilute the shares. Meanwhile the company pays down 10 million/ year of the debt making their pool of shares less and less.
Comment by daydream1 on Aug 20, 2019 7:45am
Regardless of the share price Deefield will get its money + interest back. Nuvo has to make mandatory quarterly loan payments equal to the greater of US$2.5 million and 50% of excess cash flow to Deefield to repay the senior secured loan. A higher share price is just gravy for Deefield. From Nuvo's website Financing: Deerfield has provided a binding commitment letter to Nuvo ...more  
Comment by lscfa on Aug 20, 2019 9:47am
June 26 - Deerfield Financing Agreement Amendment As a result of the previously announced United States Court of Appeals decision related to the United States patents 6,926,907 and 8,557,285 covering VIMOVO (the '907 and '285 Patents), and the potential future financial implications thereof to Nuvo, Deerfield Management Company, L.P. (Deerfield) and certain of ...more  
Comment by daydream1 on Aug 20, 2019 9:57am
Ah yes the amedment: "The amount of any prepayment so deferred would, until repaid in accordance with the amendment, be subject to an interest rate of 12.5% per annum."  Still does not look good for any investors other than Deefiled. 
Comment by ValueCap on Aug 20, 2019 1:30pm
Right, they get below prime rate interest if they never get a chance to convert the sharesat a higher price. Opportunity cost lost to them if that’s all they get 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities